Showing stock holdings,
see here
for options holdings
Broadfin Capital, LLC Q4 2014 Portfolio
Sym
Weight
Trade Impact
Company
Class
Share Change
Activity
Value Change $
Value $
* Price $
Shares
Principal
Filing 2014 Q4 - Restatement compared to 2014 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Kevin Kotler
Managing Member
New York, New York
17 Feb 2015
This restatement is being filed to revise the number of shares and values listed on the Form 13F Information Table with respect to the issuers (i) ELEVEN BIOTHERAPEUTICS INC (CUSIP: 28622106), (ii) IGNYTA INC (CUSIP: 451731103) and (iii) INFINITY PHARMACEUTICALS INC (CUSIP: 45665G303). The Form 13F Information Table Value Total is being revised accordingly.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.